Index RUT P/E 19.88 EPS (ttm) 7.37 Insider Own 7.33% Shs Outstand 17.06M Perf Week 1.22%
Market Cap 2.43B Forward P/E 14.79 EPS next Y 9.91 Insider Trans -10.43% Shs Float 15.36M Perf Month 4.56%
Income 128.15M PEG 1.54 EPS next Q 1.08 Inst Own 95.28% Short Float 8.31% Perf Quarter 2.18%
Sales 1.54B P/S 1.58 EPS this Y 10.65% Inst Trans 4.09% Short Ratio 8.23 Perf Half Y 6.14%
Book/sh 50.63 P/B 2.89 EPS next Y 10.12% ROA 7.34% Short Interest 1.28M Perf Year 21.21%
Cash/sh 5.75 P/C 25.46 EPS next 5Y 12.94% ROE 16.12% 52W Range 103.04 - 158.69 Perf YTD 13.51%
Dividend Est. - P/FCF - EPS past 5Y 16.36% ROI 12.64% 52W High -7.69% Beta 1.08
Dividend TTM - Quick Ratio 1.00 Sales past 5Y 5.71% Gross Margin 31.73% 52W Low 42.16% ATR (14) 3.51
Dividend Ex-Date - Current Ratio 1.49 EPS Y/Y TTM 37.92% Oper. Margin 13.15% RSI (14) 51.89 Volatility 1.85% 2.23%
Employees 6681 Debt/Eq 0.64 Sales Y/Y TTM 20.36% Profit Margin 8.33% Recom 1.00 Target Price 176.33
Option/Short Yes / Yes LT Debt/Eq 0.17 EPS Q/Q 3.89% Payout 0.00% Rel Volume 0.65 Prev Close 147.92
Sales Surprise 2.93% EPS Surprise 1.70% Sales Q/Q 16.76% Earnings Aug 22 BMO Avg Volume 155.19K Price 146.48
SMA20 0.17% SMA50 1.70% SMA200 6.20% Trades
Volume 101,387 Change -0.97%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-30-24 Initiated BofA Securities
Buy
$175
Sep-18-24 Initiated Wells Fargo
Overweight
$170
Jul-27-21 Initiated Imperial Capital
Outperform
$140
Dec-10-20 Initiated Oppenheimer
Outperform
$110
Nov-13-20 Initiated Berenberg
Buy
$103
Aug-24-18 Reiterated B. Riley FBR
Buy
$81 → $92.50
Jun-21-18 Downgrade Sidoti
Buy → Neutral
Feb-02-18 Downgrade Jefferies
Buy → Hold
Aug-25-17 Reiterated Jefferies
Buy
$85 → $93
May-24-17 Initiated Sidoti
Buy
Apr-12-17 Initiated Jefferies
Buy
$86
Nov-16-16 Initiated Drexel Hamilton
Buy
Aug-17-16 Reiterated The Benchmark Company
Buy
$65 → $70
Jun-21-16 Upgrade The Benchmark Company
Hold → Buy
$65
Jun-14-16 Initiated CJS Securities
Market Outperform
Apr-28-16 Downgrade The Benchmark Company
Buy → Hold
$75 → $65
Apr-13-16 Reiterated The Benchmark Company
Buy
$83 → $75
Jan-28-16 Reiterated The Benchmark Company
Buy
$102 → $83
Nov-18-15 Initiated BB&T Capital Mkts
Buy
$103
Oct-30-15 Reiterated ROTH Capital
Buy
$90 → $95
Show Previous Ratings
Oct-09-24 03:59AM
Oct-08-24 08:30AM
Sep-26-24 08:30AM
Sep-25-24 04:54AM
Sep-19-24 08:30AM
05:08AM
Loading…
Sep-16-24 05:08AM
Sep-11-24 03:43AM
Sep-10-24 07:26AM
Sep-09-24 03:42AM
Sep-04-24 09:55AM
08:30AM
Aug-26-24 12:00PM
Aug-23-24 03:43AM
(Thomson Reuters StreetEvents)
Aug-22-24 11:48AM
10:30AM
10:10AM
Loading…
10:10AM
09:16AM
(Associated Press Finance)
09:08AM
09:00AM
Aug-21-24 03:01AM
Aug-19-24 09:15AM
Aug-15-24 08:30AM
Jul-29-24 08:30AM
Jul-17-24 10:25AM
Jul-16-24 10:11PM
07:00AM
03:38AM
Jul-09-24 12:27PM
08:30AM
Jul-08-24 08:30AM
08:30AM
Loading…
Jun-24-24 08:30AM
Jun-20-24 08:30AM
Jun-18-24 08:30AM
Jun-13-24 08:30AM
Jun-06-24 02:59AM
May-31-24 08:50AM
May-30-24 08:30AM
02:41AM
May-21-24 08:30AM
May-20-24 08:30AM
03:22AM
May-15-24 08:50AM
May-13-24 08:30AM
May-10-24 03:54AM
02:40AM
May-07-24 08:30AM
May-03-24 05:00PM
04:01PM
May-01-24 05:37PM
Apr-30-24 10:57AM
Apr-29-24 08:43AM
Apr-26-24 05:05AM
(Thomson Reuters StreetEvents)
03:30AM
Apr-25-24 12:53PM
10:00AM
09:45AM
09:21AM
08:40AM
(Associated Press Finance)
08:30AM
Apr-17-24 08:30AM
Apr-16-24 11:50AM
Apr-10-24 12:37PM
Apr-09-24 08:30AM
Mar-28-24 08:30AM
Mar-26-24 08:30AM
Mar-20-24 08:50AM
Mar-14-24 08:30AM
Mar-12-24 08:30AM
Mar-11-24 08:30AM
Mar-07-24 08:30AM
Mar-04-24 08:50AM
08:30AM
Mar-01-24 08:30AM
Feb-22-24 09:55AM
09:40AM
Feb-15-24 08:50AM
Feb-13-24 08:30AM
Feb-05-24 12:00PM
Jan-30-24 12:45PM
09:55AM
09:40AM
08:50AM
Jan-27-24 10:55AM
Jan-26-24 01:56AM
(Thomson Reuters StreetEvents)
Jan-25-24 10:30AM
10:10AM
09:36AM
09:08AM
(Associated Press Finance)
09:00AM
Jan-22-24 01:07PM
Jan-17-24 08:30AM
Jan-15-24 09:10AM
Jan-11-24 08:30AM
Jan-09-24 08:30AM
Jan-08-24 10:26AM
08:30AM
Jan-04-24 08:30AM
Dec-11-23 09:40AM
Dec-06-23 08:30AM
Nov-30-23 08:30AM
OSI Systems, Inc. engages in the design and manufacture of specialized electronic systems, and components for critical applications. It operates through the following segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security segment includes security inspection systems and related services, and turnkey security screening solutions. The Healthcare segment provides patient monitoring, diagnostic cardiology, and related services. The Optoelectronics and Manufacturing segment refers to electronic components and electronic manufacturing services. The company was founded by Deepak Chopra in May 1987 and is headquartered in Hawthorne, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
CHOPRA DEEPAK PRESIDENT AND CEO Sep 16 '24 Sale 144.92 20,000 2,898,400 459,033 Sep 17 05:00 PM CHOPRA FAMILY TRUST U/A DTD 12 Officer Sep 16 '24 Proposed Sale 145.39 40,000 5,815,600 Sep 16 04:35 PM Morben Paul Keith PRES., OSI ELECTRONICS Sep 13 '24 Sale 145.04 1,107 160,559 10,077 Sep 13 09:55 PM CHIZEVER GERALD M Director Sep 11 '24 Sale 138.41 3,000 415,230 3,462 Sep 13 05:00 PM PAUL MORBEN Officer Sep 13 '24 Proposed Sale 145.04 1,107 160,562 Sep 13 04:08 PM CHIZEVER GERALD M Director Sep 11 '24 Proposed Sale 138.41 3,000 415,224 Sep 11 09:10 PM Chandra Shalabh PRES., SPACELABS HEALTHCARE Jun 12 '24 Sale 139.50 676 94,302 8,192 Jun 14 11:00 AM EDRICK ALAN I EVP & CFO Jun 03 '24 Sale 143.75 30,386 4,368,084 310,529 Jun 05 09:00 PM EDRICK ALAN I EVP & CFO Jun 05 '24 Sale 142.54 13,696 1,952,228 296,833 Jun 05 09:00 PM EDRICK ALAN I EVP & CFO May 28 '24 Sale 142.14 4,216 599,262 340,915 May 29 05:30 PM ALIABADI MANOOCHER M PRES., OPTOELECTRONICS DIV May 21 '24 Sale 143.58 2,567 368,570 81,473 May 22 09:00 PM CHOPRA DEEPAK PRESIDENT AND CEO May 15 '24 Sale 139.75 40,000 5,589,823 428,615 May 17 09:00 PM Ballhaus William Francis JR Director May 08 '24 Sale 133.98 675 90,436 25,907 May 09 06:29 PM CHIZEVER GERALD M Director May 08 '24 Sale 134.11 3,000 402,330 10,515 May 09 06:26 PM HAWKINS JAMES B Director May 08 '24 Sale 134.09 10,000 1,340,875 7,834 May 09 06:16 PM LUSKIN MEYER/ Director Apr 29 '24 Sale 134.36 6,755 907,587 20,883 May 01 05:30 PM LUSKIN MEYER/ Director Apr 30 '24 Sale 130.76 5,000 653,800 15,883 May 01 05:30 PM Morben Paul Keith PRES., OSI ELECTRONICS Apr 30 '24 Sale 133.02 310 41,236 8,834 May 01 03:25 PM SZE VICTOR S GENERAL COUNSEL Mar 11 '24 Sale 130.21 15,000 1,953,150 63,116 Mar 13 02:00 PM CHOPRA DEEPAK PRESIDENT AND CEO Jan 31 '24 Sale 129.11 20,000 2,582,200 468,615 Feb 01 09:44 PM SZE VICTOR S GENERAL COUNSEL Jan 29 '24 Sale 131.22 15,000 1,968,300 78,116 Jan 30 09:50 PM CHOPRA DEEPAK PRESIDENT AND CEO Nov 01 '23 Sale 104.34 18,028 1,881,042 498,155 Nov 03 06:30 PM CHOPRA DEEPAK PRESIDENT AND CEO Nov 02 '23 Sale 106.08 1,972 209,190 496,183 Nov 03 06:30 PM
Index RUT P/E - EPS (ttm) -0.25 Insider Own 8.35% Shs Outstand 43.39M Perf Week -5.69%
Market Cap 101.18M Forward P/E 15.47 EPS next Y 0.15 Insider Trans 0.83% Shs Float 39.97M Perf Month -18.02%
Income -10.68M PEG - EPS next Q 0.01 Inst Own 73.14% Short Float 0.79% Perf Quarter -28.83%
Sales 101.12M P/S 1.00 EPS this Y -46.43% Inst Trans -2.99% Short Ratio 2.75 Perf Half Y -46.61%
Book/sh 1.54 P/B 1.50 EPS next Y 100.00% ROA -7.86% Short Interest 0.31M Perf Year -48.21%
Cash/sh 0.09 P/C 24.98 EPS next 5Y 10.00% ROE -14.97% 52W Range 2.35 - 5.56 Perf YTD -56.64%
Dividend Est. - P/FCF 15.08 EPS past 5Y 6.80% ROI -10.28% 52W High -58.27% Beta 1.30
Dividend TTM - Quick Ratio 0.94 Sales past 5Y -1.02% Gross Margin 53.03% 52W Low -1.28% ATR (14) 0.13
Dividend Ex-Date - Current Ratio 2.05 EPS Y/Y TTM -90.44% Oper. Margin -3.74% RSI (14) 29.20 Volatility 4.40% 4.87%
Employees 416 Debt/Eq 0.62 Sales Y/Y TTM -11.36% Profit Margin -10.56% Recom 1.00 Target Price 6.25
Option/Short Yes / Yes LT Debt/Eq 0.55 EPS Q/Q -191.34% Payout - Rel Volume 0.76 Prev Close 2.37
Sales Surprise -12.51% EPS Surprise -100.00% Sales Q/Q -19.69% Earnings Aug 08 BMO Avg Volume 114.44K Price 2.32
SMA20 -11.75% SMA50 -16.75% SMA200 -35.99% Trades
Volume 86,597 Change -2.11%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-10-23 Upgrade The Benchmark Company
Speculative Buy → Buy
$3 → $4
Jan-07-21 Upgrade The Benchmark Company
Speculative Buy → Buy
Dec-09-20 Initiated Northland Capital
Outperform
$6
Nov-10-20 Initiated KeyBanc Capital Markets
Overweight
$6
Jul-08-19 Downgrade Janney
Buy → Neutral
$2
Jan-24-18 Reiterated Janney
Buy
$5 → $8
Jan-23-18 Reiterated The Benchmark Company
Buy
$6 → $10
Nov-17-16 Initiated Singular Research
Buy
$5.50
Jul-28-15 Initiated The Benchmark Company
Buy
$8
Oct-09-24 05:43PM
Oct-03-24 08:00AM
Sep-18-24 07:30AM
Sep-17-24 08:00AM
Sep-05-24 04:05PM
08:37AM
Loading…
Aug-08-24 08:37AM
(Associated Press Finance) +11.83%
08:30AM
Aug-02-24 08:00AM
Jun-06-24 04:05PM
May-23-24 04:05PM
May-16-24 04:05PM
May-08-24 10:14AM
03:03AM
May-07-24 11:56AM
08:41AM
08:15AM
Loading…
08:15AM
07:13AM
(Associated Press Finance)
07:00AM
Apr-29-24 08:45AM
Apr-09-24 09:00AM
Mar-12-24 10:30AM
Mar-11-24 08:00AM
Mar-08-24 10:48AM
Mar-07-24 10:51PM
(Thomson Reuters StreetEvents) +9.73%
01:56PM
12:53PM
07:32AM
(Associated Press Finance)
07:00AM
Mar-06-24 08:30AM
Feb-27-24 05:10PM
04:40PM
Loading…
Nov-20-23 04:40PM
Nov-09-23 04:30PM
02:28PM
Nov-07-23 09:58PM
(Thomson Reuters StreetEvents)
08:00AM
07:28AM
(Associated Press Finance)
07:00AM
Nov-06-23 04:30PM
Oct-30-23 09:00AM
Sep-18-23 08:57AM
Aug-15-23 10:20AM
Aug-08-23 09:43PM
(Thomson Reuters StreetEvents)
09:15AM
08:05AM
07:18AM
Aug-03-23 06:30PM
Jul-27-23 06:36PM
Jun-22-23 07:55AM
Jun-21-23 08:50AM
Jun-20-23 08:01AM
Jun-13-23 12:21PM
May-25-23 08:50AM
May-24-23 08:26AM
May-23-23 10:17AM
May-09-23 09:40AM
08:50AM
07:15AM
May-02-23 05:01PM
08:35AM
Apr-27-23 06:14PM
Apr-26-23 12:02AM
(Thomson Reuters StreetEvents) +6.48%
Apr-25-23 08:41AM
08:01AM
Apr-18-23 05:10PM
Apr-17-23 04:45PM
Apr-11-23 08:28AM
Mar-28-23 06:14AM
(Simply Wall St.) +12.28%
Mar-20-23 02:00PM
Mar-16-23 05:14PM
(GlobeNewswire) +5.68%
+7.89%
09:25AM
Mar-13-23 02:49AM
Mar-09-23 10:59PM
(Thomson Reuters StreetEvents) +7.26%
07:00AM
Mar-06-23 05:09AM
Feb-28-23 04:10PM
Jan-04-23 10:43AM
Dec-12-22 08:30AM
Dec-05-22 05:09AM
Nov-08-22 06:05PM
04:01PM
Nov-07-22 12:30PM
Nov-02-22 05:15PM
Sep-26-22 10:23AM
Aug-24-22 06:11AM
Aug-03-22 10:48PM
Jul-28-22 10:39AM
Jul-26-22 04:50PM
Jun-15-22 08:40AM
May-29-22 08:46AM
May-16-22 09:35AM
May-04-22 08:25AM
07:00AM
May-03-22 05:25PM
Apr-26-22 09:00AM
Apr-21-22 04:05PM
Apr-19-22 08:26AM
Mar-08-22 07:00AM
Feb-21-22 04:30PM
Feb-18-22 06:17AM
Feb-03-22 05:38PM
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Green James W Chief Executive Officer Jun 13 '24 Buy 2.91 10,000 29,100 3,111,091 Jun 14 04:02 PM Green James W Chief Executive Officer Jun 06 '24 Buy 3.07 20,000 61,400 3,101,091 Jun 07 04:02 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
